Gene · 3399
Papers2,841
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 2,841
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Plasmacytoid Dendritic Cells in Cancers. | Front Immunol | 2021 | 34737750 | PubTator, text mining | PubMed |
| Smad4 controls signaling robustness and morphogenesis by differentially contributing to the Nodal and BMP pathways. | Nat Commun | 2021 | 34737283 | PubTator, text mining | PubMed |
| Single-cell RNA transcriptome reveals the intra-tumoral heterogeneity and regulators underlying tumor progression in metastatic pancreatic ductal adenocarcinoma. | Cell Death Discov | 2021 | 34732701 | PubTator, text mining | PubMed |
| Integrated Genomic Profiling and Drug Screening of Patient-Derived Cultures Identifies Individualized Copy Number-Dependent Susceptibilities Involving PI3K Pathway and 17q Genes in Neuroblastoma. | Front Oncol | 2021 | 34722256 | PubTator, text mining | PubMed |
| ID3 promotes homologous recombination via non-transcriptional and transcriptional mechanisms and its loss confers sensitivity to PARP inhibition. | Nucleic Acids Res | 2021 | 34718742 | PubTator, text mining | PubMed |
| LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer. | Commun Biol | 2021 | 34716410 | PubTator, text mining | PubMed |
| Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeostatic Signaling. | Curr Psychopharmacol | 2021 | 34707968 | PubTator, text mining | PubMed |
| Down-regulated LINC00115 inhibits prostate cancer cell proliferation and invasion via targeting miR-212-5p/FZD5/Wnt/β-catenin axis. | J Cell Mol Med | 2021 | 34697900 | PubTator, text mining | PubMed |
| Understanding T cell aging to improve anti-viral immunity. | Curr Opin Virol | 2021 | 34688983 | PubTator, text mining | PubMed |
| Insights into Bone Morphogenetic Protein-(BMP-) Signaling in Ocular Lens Biology and Pathology. | Cells | 2021 | 34685584 | PubTator, text mining | PubMed |
| CD8 T Cell Vaccines and a Cytomegalovirus-Based Vector Approach. | Life (Basel) | 2021 | 34685468 | PubTator, text mining | PubMed |
| Pendred Syndrome, or Not Pendred Syndrome? That Is the Question. | Genes (Basel) | 2021 | 34680964 | PubTator, text mining | PubMed |
| Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment. | Biomolecules | 2021 | 34680031 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma. | Nat Commun | 2021 | 34663816 | PubTator, text mining | PubMed |
| Transcription factor 3 (TCF3) combined with histone deacetylase 3 (HDAC3) down-regulates microRNA-101 to promote Burkitt lymphoma cell proliferation and inhibit apoptosis. | Bioengineered | 2021 | 34658308 | PubTator, text mining | PubMed |
| Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer. | Cancer Cell | 2021 | 34653364 | PubTator, text mining | PubMed |
| Treatment of Sjögren's Syndrome with Mesenchymal Stem Cells: A Systematic Review. | Int J Mol Sci | 2021 | 34638813 | PubTator, text mining | PubMed |
| Poly(ADP)-Ribosylation Inhibition: A Promising Approach for Clear Cell Renal Cell Carcinoma Therapy. | Cancers (Basel) | 2021 | 34638458 | PubTator, text mining | PubMed |
| Heterogeneity of Circulating Tumor Cell Neoplastic Subpopulations Outlined by Single-Cell Transcriptomics. | Cancers (Basel) | 2021 | 34638368 | PubTator, text mining | PubMed |
| Defining the Role of GLI/Hedgehog Signaling in Chemoresistance: Implications in Therapeutic Approaches. | Cancers (Basel) | 2021 | 34638233 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3399/papers?page=43